Loading…
Back To Schedule
Wednesday, June 27 • 4:00pm - 5:15pm
#388: Using Patient-Centric Outcomes to Engage Patients in Shared Treatment Decision Making

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-679-L04-P; CME 1.25; IACET 1.25; RN 1.25

This session will briefly review for the audience what are patient-reported outcomes and real world evidence. Speakers will then review the types of data that can be gathered, analyzed, and then communicated to patients and healthcare providers to assist in treatment decisions. Examples of how this data has been effectively communicated in a variety of channels will be provided.

Learning Objectives

Identify types of patient-relevant evidence collected in the clinical development and the real-world settings; Describe how patient-reported outcomes are generated, evaluated, and communicated to assist in informed treatment decision making; Discuss strategies to educate medical information departments on the value of real world evidence and patient-reported outcomes and incorporated this data in communications.

Chair

Sara Doshi, PharmD

Speaker

How Can Patient-Reported Data Inform Shared Treatment Decision-Making?
Emily Freeman, PhD, MSc

Generating Patient-Reported Outcomes Evidence to Provide Meaningful Insights for Treatment Decision-Making
Agnes Hong, PharmD

Bringing Patient-Centric Outcomes to Customers
Linda Wang, PharmD


Speakers
avatar for Sara Doshi

Sara Doshi

Director, Medical Information Strategy and Capabilities, GMI, Eli Lilly and Company
Sara graduated with her PharmD from Butler University and then completed the Purdue University/Eli Lilly and Company Drug Information Residency. She then accepted a role with Global Medical Information (GMI) at Lilly. Sara spent several years supporting numerous products/therapeutic... Read More →
avatar for Emily Freeman

Emily Freeman

Director, Patient Centered Outcomes, AbbVie, Inc.
Dr. Emily Freeman is a social/behavioral scientist interested in the development of evidence based communication tools to facilitate decision making between patients and healthcare providers. Dr. Freeman is exploring how medical evidence (i.e. risk, benefit, and health outcomes) is... Read More →
avatar for Agnes Hong

Agnes Hong

Outcomes Research Scientist, Oncology, Genentech, A Member of the Roche Group
Agnes Hong received her Doctor of Pharmacy from Rutgers University and completed a 2-year post-doctoral PharmD Fellowship with Pfizer Inc in the Medical Affairs and Health Economics Outcomes Research groups. She joined Genentech Inc as part of the Oncology Patient-Centered Outcomes... Read More →
LW

Linda Wang

Medical Communications Leader, Genentech, A Member of the Roche Group
Linda Wang is currently a medical communications leader supporting the genitourinary cancers franchise within US Medical Affairs at Genentech. She previously led the Avastin franchise, covering lung, renal cell, brain, and colorectal cancers. She received her PharmD from Northeastern... Read More →

Wednesday June 27, 2018 4:00pm - 5:15pm
Room 210C Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  04: MedAffairs-SciComm, Session